** Shares of laboratory services provider Labcorp Holdings LH.N fall 4.2% to $220.08
** Co posts Q1 revenue of $3.35 bilion, missing analysts' estimate of $3.40 billion, according to data compiled by LSEG
** However, co reports Q1 adj. profit of $3.84 per share, beating analysts' estimate of $3.74 per share
** Co's diagnostic laboratories business grew 6% to $2.63 billion in the quarter
** Co raises lower end of its 2025 profit forecast to $15.70 per share from $15.60 previously, maintains upper end at $16.40 per share
** "While the macroeconomic environment remains dynamic, the critical nature of the work we do in diagnostics and drug development positions us well for success in 2025 and beyond," says CEO Adam Schechter
** As of last close, LH had risen 0.12% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.